Glow Stack

Glow Stack — BPC-157 + TB-500 + GHK-Cu Bundle

The Glow Stack is the scientific designation for the BPC-157 + TB-500 + GHK-Cu bundle — a three-part peptide combination for comprehensive regeneration research. Each component targets a distinct level of the recovery process. As a result, the Glow Stack covers the entire regeneration cascade: from local angiogenesis and tissue repair, through systemic cell migration, to extracellular matrix synthesis and gene expression modulation.

Furthermore, the combination is based on strong scientific rationale. Research indicates that BPC-157, TB-500, and GHK-Cu activate overlapping yet mechanistically distinct pathways. For instance, GHK-Cu promotes VEGF expression for new blood vessel formation. TB-500 mobilizes endothelial progenitor cells for vascular remodeling. BPC-157 then activates the FAK-paxillin pathway for tissue regeneration. Together, these three peptides create a synergistic research model that no single peptide can offer.

What Is the Glow Stack?

The name “Glow Stack” — also written as “GLOW blend” — is an established designation in the international research community for the specific combination of BPC-157, TB-500, and GHK-Cu. Multiple peptide suppliers and research publications use the name to describe the triple-peptide stack that addresses the complete regeneration cascade from three complementary perspectives.

Specifically, the BPC-157 TB-500 GHK-Cu bundle works as follows: BPC-157 provides the initial response to tissue damage via nitric oxide signaling and growth factor modulation. TB-500 subsequently coordinates cellular migration and reorganization via actin regulation. GHK-Cu concludes the cycle by restoring the extracellular matrix, synthesizing new collagen fibers, and modulating underlying gene expression. Thus, the Glow Stack completes the entire recovery cycle at a molecular level.

BPC-157: Initial Response and Vascular Signaling

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein sequence in human gastric juice. It is one of the most extensively studied regenerative peptides in preclinical literature. Furthermore, BPC-157 distinguishes itself by its exceptional stability in biological environments — it is resistant to gastric acid degradation and enzymatic hydrolysis.

At a molecular level, BPC-157 modulates multiple pathways simultaneously. First, it stimulates angiogenesis via upregulation of VEGFR2 — the receptor for vascular endothelial growth factor. Second, it activates the FAK-paxillin signaling pathway, which enhances cell migration and tissue adhesion. Third, it modulates nitric oxide synthase activity, thereby regulating local inflammation and vascular tone.

Scientists also investigate BPC-157 for its neuroprotective properties, gastroprotection, and central nervous system recovery. This makes it the most versatile peptide in the Glow Stack — active in multiple tissue types simultaneously.

What Do Scientists Research with BPC-157 in the Glow Stack?

• Angiogenesis via VEGFR2 upregulation without increasing VEGF-A itself
• FAK-paxillin activation for cell migration and tissue adhesion
• Nitric oxide signaling modulation for vascular tone and local inflammation
• Tendon and ligament regeneration via tenocyte proliferation and collagen synthesis
• Gastroprotection and intestinal barrier repair in gastrointestinal models

Scientific References — BPC-157

• Chang C-H, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110:774–80. PubMed PMID 21030672
• Sikiric P, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2018. PubMed PMID 30915550
• Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. PMC. 2025. PMC12753158
• Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. PMC. 2024. PMC12313605

TB-500: Systemic Cell Migration and Tissue Remodeling

TB-500 is a synthetic fragment of Thymosin Beta-4 — a naturally occurring peptide present in virtually all nucleated cells of the human body. Thymosin Beta-4 is the most abundant and biologically active member of the beta-thymosin family. The body releases it upon tissue damage to initiate cell repair.

The defining mechanism of TB-500 is actin-sequestering activity. TB-500 binds G-actin in a 1:1 ratio, thereby regulating actin polymerization in damaged cells. This significantly increases cell migration to the site of injury. In rat models, this led to 42–61% higher re-epithelialization compared to controls — a consistent and robust preclinical result.

Furthermore, TB-500 activates integrin-linked kinase (ILK) signaling pathways and upregulates VEGF expression. This promotes angiogenesis complementary to BPC-157, but via a different molecular pathway. Simultaneously, TB-500 reduces pro-inflammatory cytokines such as IL-6 and TNF-α — which favorably influences the inflammatory environment for tissue repair.

What Do Scientists Research with TB-500 in the Glow Stack?

• Actin-sequestering activity (1:1 binding with G-actin) for cell migration
• Angiogenesis via ILK signaling pathways and VEGF upregulation
• Reduction of IL-6 and TNF-α in inflammatory models
• Re-epithelialization and wound contraction in full-thickness wound models
• Connective tissue repair with reduced scar formation

Scientific References — TB-500

• Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–8. PubMed PMID 10469335
• Crockford D, et al. Thymosin beta(4): structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010;1194:179–89. PubMed PMID 20536467
• Maar K, et al. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State. Cells. 2021;10(6):1343. PMC8228050
• Philp D, et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113–5. PubMed PMID 15037013

GHK-Cu: Extracellular Matrix, Gene Expression, and Antioxidant Action

GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is the third component of the Glow Stack and is responsible for the deepest level of regeneration. The peptide regulates gene expression on a large scale — analyses via the Broad Institute's Connectivity Map show modulation of over 4,000 human genes. This adds a unique dimension that BPC-157 and TB-500 cannot offer.

For collagen synthesis, the results are particularly well-documented. GHK-Cu stimulates collagen synthesis in fibroblasts even at picomolar concentrations. Furthermore, it increases decorin production by 302% and stimulates glycosaminoglycan accumulation in skin fibroblasts. This provides the structural building blocks for sustained tissue remodeling after initial repair by BPC-157 and TB-500.

Additionally, GHK-Cu possesses potent anti-inflammatory and antioxidant properties. Research shows that it significantly reduces pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β. Simultaneously, it increases the activity of antioxidant enzymes such as superoxide dismutase and catalase. This protects cells from oxidative stress during the recovery process.

Finally, GHK-Cu fully restores the function of irradiated fibroblasts to the level of non-irradiated controls. This demonstrates that it not only builds new tissue but also actively repairs damaged tissue — a unique property within the Glow Stack.

What Do Scientists Research with GHK-Cu in the Glow Stack?

• Collagen synthesis in fibroblasts — active even at picomolar concentrations
• Modulation of over 4,000 human genes via Connectivity Map analyses
• Reduction of TNF-α, IL-6, and IL-1β in inflammatory and fibrosis models
• Antioxidant enzyme activity — superoxide dismutase, catalase, glutathione peroxidase
• Restoration of irradiated fibroblasts and stimulation of DNA repair genes
• Angiogenesis via VEGF upregulation complementary to BPC-157 and TB-500

Scientific References — GHK-Cu

• Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238:343–346. PubMed PMID 3169264
• Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMC6073405
• Pickart L, et al. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging. Oxid Med Cell Longev. 2012. PMC3359723
• Zhang Q, et al. GHK-Cu attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Front Mol Biosci. 2022;9:925700. PubMed PMID 35911031
• Frontiers in Pharmacology. GHK-Cu on experimental colitis model via SIRT1/STAT3 pathway. 2025. Frontiers Pharmacol. 2025
• Pollard JD, et al. Effects of Copper Tripeptide on the Growth and Expression of Growth Factors by Normal and Irradiated Fibroblasts. Arch Facial Plast Surg. 2005;7(1):27–31. DOI 10.1001/archfaci.7.1.27

Why the Glow Stack Is More Than the Sum of Its Parts

The scientific strength of the Glow Stack lies in three complementary levels of tissue regeneration. BPC-157 addresses the initial response: it stabilizes vascular tone, promotes angiogenesis via VEGFR2, and reduces local inflammation. TB-500 then coordinates the cellular reorganization phase: it mobilizes cells to the injury site via actin regulation and promotes systemic vascular remodeling. Finally, GHK-Cu concludes the maturation phase: it builds new extracellular matrix, modulates thousands of genes, and protects cells from oxidative damage throughout the regeneration cycle.

Furthermore, the angiogenic effects of the three peptides reinforce each other. GHK-Cu and TB-500 both promote angiogenesis, but via different routes — VEGF upregulation versus ILK activation. BPC-157 adds VEGFR2 upregulation to this. This creates triple angiogenic activation — a mechanistic argument for the synergistic action of the Glow Stack.

Kortom: de BPC-157 TB-500 GHK-Cu bundel adresseert de complete regeneratiecascade vanuit drie mechanistisch onderscheidende maar onderling versterkende routes. Daardoor is het een uniek onderzoeksmodel voor wie multi-pathway weefselregeneratie wil bestuderen.

Toepassingen in Onderzoek

Onderzoekers kiezen de Glow Stack voor de volgende studiegebieden:

• Multi-mechanism tissue regeneration and wound healing models
• Angiogenesis — triple activation via VEGF, ILK, and VEGFR2
• Collagen biosynthesis, decorin production, and extracellular matrix remodeling
• Gene expression modulation via copper peptide in combination with regenerative peptides
• Anti-inflammatory action — reduction of TNF-α, IL-6, and IL-1β via multiple pathways
• Skin aging, dermal repair, and photoaging research
• Post-injury recovery of tendons, ligaments, and muscle tissue in sports science research

Who Is the Glow Stack For?

The BPC-157 + TB-500 + GHK-Cu bundle is ideally suited for:

• Researchers wishing to study the complete regeneration cascade in a single protocol
• Dermatologists and skin scientists researching tissue repair and collagen remodeling
• Sports scientists modeling connective tissue and musculoskeletal recovery
• Biochemists studying multi-pathway angiogenesis and anti-inflammatory mechanisms
• Longevity researchers investigating gene expression modulation via peptides

Bundle Contents

• BPC-157 — research-grade lyophilized peptide (≥98% purity, HPLC-verified)
• TB-500 — research-grade lyophilized peptide (≥98% purity, HPLC-verified)
• GHK-Cu — research-grade lyophilized copper peptide (≥98% purity, HPLC-verified)

All peptides are supplied as lyophilized powder for reconstitution for research purposes. HPLC and mass spectrometry certificates from accredited independent laboratories are available upon request.

Frequently Asked Questions about the Glow Stack

What is the difference between the Glow Stack and the Wolverine Stack?

The Wolverine Stack combines BPC-157 and TB-500 — focusing on local and systemic tissue repair. The Glow Stack adds GHK-Cu as a third component. This expands the Glow Stack protocol with a copper peptide that adds extracellular matrix synthesis, gene expression modulation, and antioxidant protection. In short: the Glow Stack is the extended version of the Wolverine Stack with an additional regenerative level.

Why is the combination called the Glow Stack or GLOW blend?

The name “Glow Stack” or “GLOW blend” originated in the international research community as a descriptive term for the triple combination. The name refers to the stack's broad regenerative spectrum — from tissue repair and angiogenesis to skin remodeling and gene expression. Multiple peptide suppliers and research publications now use the term as a standardized name.

Are the three peptides in the Glow Stack approved for human use?

No. BPC-157 does not have FDA approval and is on the FDA Category 2 list for bulk substances. TB-500 also lacks approval from the FDA, EMA, or any other regulatory authority for therapeutic use. GHK-Cu has been used in topical skincare products but does not have approval for injectable therapeutic applications. We offer this bundle exclusively for scientific laboratory research.

---

Full Scientific Reference List

1. Chang C-H, et al. BPC 157 on tendon healing: outgrowth, cell survival, migration. J Appl Physiol. 2011;110:774–80. PubMed PMID 21030672
2. Sikiric P, et al. BPC 157 and musculoskeletal soft tissue healing. Cell Tissue Res. 2018. PubMed PMID 30915550
3. Therapeutic Peptides in Orthopaedics. PMC. 2025. PMC12753158
4. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. PMC. 2024. PMC12313605
5. Crockford D, et al. Thymosin beta(4): structure, function, and biological properties. Ann N Y Acad Sci. 2010;1194:179–89. PubMed PMID 20536467
6. Maar K, et al. Thymosin Beta-4: New Directions in Anti-Aging Regenerative Therapies. Cells. 2021;10(6):1343. PMC8228050
7. Philp D, et al. Thymosin beta4 promotes angiogenesis and wound healing. Mech Ageing Dev. 2004;125(2):113–5. PubMed PMID 15037013
8. Maquart FX, et al. Stimulation of collagen synthesis by GHK-Cu in fibroblast cultures. FEBS Lett. 1988;238:343–346. PubMed PMID 3169264
9. Pickart L, Margolina A. Regenerative and Protective Actions of GHK-Cu. Int J Mol Sci. 2018;19(7):1987. PMC6073405
10. Pickart L, et al. GHK-Cu in Prevention of Oxidative Stress and Degenerative Aging. Oxid Med Cell Longev. 2012. PMC3359723
11. Zhang Q, et al. GHK-Cu attenuates pulmonary emphysema and inflammation. Front Mol Biosci. 2022;9:925700. PubMed PMID 35911031
12. GHK-Cu on colitis model via SIRT1/STAT3 signaling. Frontiers in Pharmacology. 2025. Frontiers Pharmacol. 2025
13. Pollard JD, et al. GHK-Cu on Normal and Irradiated Fibroblasts. Arch Facial Plast Surg. 2005;7(1):27–31. DOI 10.1001/archfaci.7.1.27

---

For Research Purposes Only — Disclaimer: This product is intended solely for in vitro and laboratory research. It is not intended for use in humans or animals, self-administration, diagnosis, treatment, or prevention of any disease or medical condition. BPC-157, TB-500, and GHK-Cu do not have approval from the FDA, EMA, or any equivalent regulatory authority for therapeutic use in humans. Researchers must comply with all applicable local laws, regulations, and institutional requirements. Keep out of reach of children. Handle according to Good Laboratory Practice (GLP) guidelines.

More background information: see the peptide guide for context, considerations, and related information.